MedPath

Feasibility study of intratumoral gold marker placement and cone beam CT for image- guided radiotherapy in rectal cancer

Withdrawn
Conditions
rectal cancer
10017991
Registration Number
NL-OMON38849
Lead Sponsor
Medisch Universitair Ziekenhuis Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

- Patients with histological or cytological proven rectal cancer, treated with long course external beam radiotherapy (both conformal and IMRT radiation therapy techniques are allowed)
- Age ><= 18 years
- Have given written informed consent before patient registration

Exclusion Criteria

Patients using anticoagulants (platelet aggregation inhibitors and coumarines)

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary endpoint is the concordance index between observers on kV CBCT</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary endpoints:<br /><br>- % of marker loss<br /><br>- intra-observer variation in GTV localization with and without markers<br /><br>- tumor movement<br /><br>- use of goldmarkers for automatic online matching<br /><br>- development of SIB technique</p><br>
© Copyright 2025. All Rights Reserved by MedPath